These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13349934)

  • 1. [Causes of functional disorders of the skeletal muscles in Graves-Basedow disease].
    MACZYNSKI B; GACA W
    Pr Kom Med Dosw; 1956; 13(3):1-27. PubMed ID: 13349934
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of thyroxin on skeletal muscle function.
    SCHWARTZ NB; LEIN A
    Am J Physiol; 1955 Jul; 182(1):5-11. PubMed ID: 13248932
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiological, clinical, therapeutic and evolutive aspects of Basedow-Graves disease in the Depatment of Internal Medicine at CHU Aristide Le Dantec, Dakar (Senegal)].
    Diagne N; Faye A; Ndao AC; Djiba B; Kane BS; Ndongo S; Pouye A
    Pan Afr Med J; 2016; 25():6. PubMed ID: 28154699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and endocrinological studies on Graves' disease.
    SHIRAKAWA G
    Endocrinol Jpn; 1955 Sep; 2(3):241-6. PubMed ID: 13285439
    [No Abstract]   [Full Text] [Related]  

  • 5. Electromyographical studies on Graves' disease.
    KAWAMURA K
    Tohoku J Exp Med; 1955 Sep; 62(2):129-35. PubMed ID: 13291368
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acromegaly and Graves-Basedow disease. Report of 3 cases].
    Burgos Peláez R; Simó Canonge R; Hernández-Pascual C; Mesa Manteca J
    Med Clin (Barc); 1994 Jul; 103(5):179-80. PubMed ID: 7934281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of angiotensin-converting enzyme in women with hyperthyroidism accompanying Graves-Basedow disease].
    Zdrojewicz Z
    Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):1004-5. PubMed ID: 1339053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of action of short duration of ACTH and cortisone in Graves-Basedow disease].
    MACZYNSKI B; SPORNY B
    Pol Tyg Lek (Wars); 1956 Oct; 11(44):1857-61. PubMed ID: 13419650
    [No Abstract]   [Full Text] [Related]  

  • 9. [The neuroregulatory theory of Basedow's disease and its anatomic and physiological significance].
    BRAEUCKER W
    Ther Ggw; 1953 Jul; 92(7):249-55. PubMed ID: 13102402
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rarely encountered association of hyperthyroidism in the form of Graves-Basedow disease with vitiligo].
    Hrycek A; Szwed Z; Badowski R
    Wiad Lek; 1994 Mar; 47(5-6):213-5. PubMed ID: 7941564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sonography of the retrobulbar space in autoimmune hyperthyroidism of the Basedow type].
    Schillings S; Wagner J; Franzen W; Wildmeister W
    Z Gesamte Inn Med; 1990 Nov; 45(22):678-83. PubMed ID: 2099028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Graves Basedow disease following treatment with magistral formulae for obesity. Jod-Basedow phenomenon?].
    Goday-Arnó A; García Rico A; Martínez-Riquelme A; Cano-Pérez JF
    Rev Clin Esp; 1996 Aug; 196(8):536-8. PubMed ID: 8984540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electromyographic studies in endocrine ophthalmopathy].
    PAPST W; ESSLEN E
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1961; 63():154-8. PubMed ID: 14483766
    [No Abstract]   [Full Text] [Related]  

  • 14. [What is the role of the pituitary gland in the physiopathology of Basedow's disease?].
    RIVIERE J
    J Med Bord; 1956 Nov; 133(11):1139-47. PubMed ID: 13385607
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism.
    Rybus-Kalinowska B; Zwirska-Korczala K; Kalinowski M; Kukla M; Birkner E; Jochem J
    Pol Arch Med Wewn; 2008; 118(7-8):420-5. PubMed ID: 18714737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of apathetic form of Graves-Basedow disease with hyperthyroidism].
    Hanzlik J; Ilenda M
    Wiad Lek; 1973 Aug; 26(15):1449-51. PubMed ID: 4740974
    [No Abstract]   [Full Text] [Related]  

  • 17. [Free radical concepts in the etiopathogenesis of Graves-Basedow disease].
    Komosińska-Vassev K; Olczyk K; Winsz K
    Postepy Hig Med Dosw; 2000; 54(2):225-37. PubMed ID: 10857382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal rate of radiosodium (Na24) from human orbit in Graves's disease and in health.
    DAY RM; WERNER SC
    AMA Arch Ophthalmol; 1954 Jul; 52(1):85-90. PubMed ID: 13170869
    [No Abstract]   [Full Text] [Related]  

  • 19. [Suppressibility of the thyroid function following radioiodine therapy of hyperthyroidism. When is Basedow-Graves disease completely cured?].
    Fazakas S; Kiss B; Petrányi G
    Orv Hetil; 1972 May; 113(20):1059-61. PubMed ID: 5067474
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current problems and prospects of classification of hyperthyroidisms, with special reference to the pathogenesis of Graves-Basedow disease].
    Borghi A; Maiello M
    Riv Crit Clin Med; 1966 Aug; 66(3):205-17. PubMed ID: 6015045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.